| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |